← Back to Search

Corticosteroid

Topical Treatment for Eczema

N/A
Recruiting
Led By Steven R Feldman, MD, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of skin dermatitis
Age > 9
Must not have
Patients without the diagnosis of skin dermatitis
Body Surface Area (BSA) affected <2%
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7
Awards & highlights
No Placebo-Only Group

Summary

This trial highlights the problem of patients not taking their medications as prescribed. About half of people with chronic diseases do not follow their treatment plans, leading to high hospital costs. This issue is common in dermat

Who is the study for?
This trial is for individuals with atopic dermatitis, commonly known as eczema. It's designed to help those who struggle with following their medication regimen consistently.
What is being tested?
The study is testing the effectiveness of a mobile app in improving treatment adherence compared to standard care. Participants will also be shown how to apply triamcinolone cream properly.
What are the potential side effects?
While the trial focuses on app usage and demonstration, side effects may relate primarily to the use of triamcinolone cream which can include skin irritation, dryness, or infections.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with skin dermatitis.
Select...
I am older than 9 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have skin dermatitis.
Select...
Less than 2% of my body is affected by my condition.
Select...
I cannot come back for a follow-up in one week.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 7 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Amount of Topical Medication Dispensed - Demonstration Group
Amount of Topical Medication Dispensed - Mobile Application Group
Amount of Topical Medication Dispensed - Standard of Care Group
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Written/verbal instructions onlyExperimental Treatment1 Intervention
Standard of care written/verbal instructions only
Group II: Mobile ApplicationExperimental Treatment1 Intervention
Additional mobile application that provides instructions to apply the medication (triamcinolone cream)
Group III: DemonstrationActive Control1 Intervention
Observe a live demonstration instructing how to dispense 1 fingertip unit (FTU) of medication (triamcinolone cream) per 1% body surface area

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,395 Previous Clinical Trials
2,460,175 Total Patients Enrolled
Steven R Feldman, MD, PhDPrincipal InvestigatorWake Forest University Health Sciences
14 Previous Clinical Trials
573 Total Patients Enrolled
~18 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top